METABOLIC AND HEMODYNAMIC-EFFECTS OF MAGNESIUM SUPPLEMENTATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:47
|
作者
ZEMEL, PC [1 ]
ZEMEL, MB [1 ]
URBERG, M [1 ]
DOUGLAS, FL [1 ]
GEISER, R [1 ]
SOWERS, JR [1 ]
机构
[1] CIBA GEIGY CORP,DIV PHARMACEUT,SUMMIT,NJ 07901
来源
关键词
Blood pressure; Cation metabolism; Lipids; Magnesium;
D O I
10.1093/ajcn/51.4.665
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg asparate (20 mmol elemental Mg twice daily) and six received placebo for 3 mo. In comparison with placebo treatment, magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism. These results demonstrate that in magnesium-repleted hypertensive subjects, magnesium supplementation does not affect blood pressure or lipids probably because magnesium has no effect on cellular cation metabolism in magnesium-replete individuals.
引用
收藏
页码:665 / 669
页数:5
相关论文
共 50 条
  • [1] HEMODYNAMIC-EFFECTS OF KETANSERIN IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    WOITTIEZ, AJJ
    WENTING, GJ
    MANINTVELD, AJ
    BOOMSMA, F
    SCHALEKAMP, MADH
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1983, 26 (02): : 60 - 61
  • [2] HEMODYNAMIC-EFFECTS OF GUANFACINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    COHEN, AA
    FELDSTEIN, CA
    SABARIS, RP
    BURUCUA, JE
    [J]. MEDICINA-BUENOS AIRES, 1982, 42 (06) : 919 - 920
  • [3] HEMODYNAMIC-EFFECTS OF GUANFACINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    ISHIGURO, M
    HIRANO, T
    WATANABE, S
    ARAKAWA, M
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 47 (06): : 1082 - 1094
  • [4] METABOLIC AND HEMODYNAMIC-EFFECTS OF ORAL CALCIUM THERAPY IN ESSENTIAL-HYPERTENSION
    GOMEZFERNANDEZ, P
    PEREZMIJARES, R
    RAMOS, M
    BENAVIDES, B
    ALMARAZ, M
    VARGAS, JC
    CASTRO, A
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (06) : 1598 - 1598
  • [5] HEMODYNAMIC-EFFECTS OF PIRETANIDE IN ESSENTIAL-HYPERTENSION
    WIECHMANN, HW
    GROTZ, J
    [J]. HERZ KREISLAUF, 1987, 19 (04): : 222 - 227
  • [6] HEMODYNAMIC-EFFECTS OF GUANFACINE IN ESSENTIAL-HYPERTENSION
    FELDSTEIN, CA
    COHEN, AA
    SABARIS, RP
    BURUCUA, JE
    [J]. CLINICAL THERAPEUTICS, 1984, 6 (03) : 325 - 334
  • [7] HEMODYNAMIC-EFFECTS OF PERINDOPRIL IN ESSENTIAL-HYPERTENSION
    ASMAR, RG
    PANNIER, B
    LAURENT, ST
    BENETOS, A
    DAOU, J
    SAFAR, M
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1990, 4 : 35 - 44
  • [8] IMMEDIATE HEMODYNAMIC-EFFECTS OF URAPIDIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    KOBRIN, I
    AMODEO, C
    VENTURA, HO
    MESSERLI, FH
    FROHLICH, ED
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06): : 722 - 725
  • [9] HEMODYNAMIC-EFFECTS OF CELIPROLOL IN ESSENTIAL-HYPERTENSION
    FROHLICH, ED
    KETELHUT, R
    KAESSER, UR
    LOSEM, CJ
    MESSERLI, FH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (05): : 509 - 514
  • [10] HEMODYNAMIC-EFFECTS OF PENBUTOLOL IN ESSENTIAL-HYPERTENSION
    COHEN, AA
    FELDSTEIN, CA
    SABARIS, RP
    BURUCUA, JE
    [J]. MEDICINA-BUENOS AIRES, 1983, 43 (06) : 817 - 818